New Investigator Gateway Awards for Collaborative T1D Research (R03)

Research Focus

This program supports new and early-stage investigators pursuing careers in type 1 diabetes (T1D) research through embedded positions within established collaborative consortia. T1D is an autoimmune disease destroying insulin-producing beta cells in the pancreas, leading to loss of glucose control and complications affecting the heart, eye, nerves, kidney, and urogenital systems. The Gateway Award funds high-quality basic, translational, and clinical research addressing significant barriers in T1D that align with one of four major research networks: the Human Islet Research Network (HIRN), Type 1 Diabetes TrialNet, the Environmental Determinants of Diabetes in the Young (TEDDY) Study, and the Collaborative Research in Complementary and Alternative Medicine for Diabetes (CRCAMD). Research priorities span beta cell death and survival, pancreatic tissue organization, autoimmune diabetes modeling, biomarker development, immune-cell engineering, clinical trial design, environmental risk factors, and complementary medicine approaches. The program aims to establish junior faculty in T1D-oriented career paths and prepare them for competitive R01 submissions while bringing new perspectives to existing research networks.

At a Glance

• Who can apply: New Investigators (NI) and Early Stage Investigators (ESI) from diverse scientific backgrounds pursuing T1D research careers
• Funding & project length: R03 small grant mechanism; specific amounts and duration not stated
• Award mechanism: R03 (Clinical Trial Not Allowed)
• Key dates: Open May 26, 2025; due June 26, 2025 and March 6, 2026; earliest start April 2026 and December 2026; expires March 7, 2026
• Best fit for: Junior faculty in immunology, cell biology, biomarker development, or translational diabetes research embedded within consortium networks

Note: This funding opportunity has expired as of March 7, 2026. Limited case-by-case submissions may be accepted; contact the eRA Service Desk for guidance.